Disclosure of Findings Sample Clauses

Disclosure of Findings. Nothing in the DUA, including but not limited to Section 8, prohibits Users from discussing or reporting on specific providers or suppliers (including individual physicians) in a manner consistent with A-1.
AutoNDA by SimpleDocs
Disclosure of Findings. The Recipient agrees not to disclose direct findings, listings, or information derived from the CMS Data file(s), with or without direct identifiers, if such findings, listings, or information can, by themselves or in combination with other data, be used to deduce an individual’s identity. Examples of such data elements include, but are not limited to geographic location, age if > 89, sex, diagnosis and procedure, admission/discharge date(s), or date of death. The Recipient agrees that any use of CMS data in the creation of any document (manuscript, table, chart, study, report, etc.) must adhere to CMS’s current cell size suppression policy. This policy stipulates that no cell (e.g. admittances, discharges, patients, services) 10 or less may be displayed. Also, no use of percentages or other mathematical formulas may be used if they result in the display of a cell 10 or less. The Recipient also agrees not to disclose, with or without direct physician identifiers, direct findings, listings, or information derived from CMS data file(s) if such findings, listings, or information can, by themselves or in combination with other data, be used to deduce a physician’s total Medicare reimbursements.
Disclosure of Findings. The Recipient Agrees that it shall not publish any MassHealth Data, or any data derived or extracted from such data, in any paper, report, website, statistical tabulation, or similar documentation unless such paper, report, website, statistical tabulation, or similar documentation conforms to the standards for de-identification set forth under 45 C.F.R. §§ 164.514(a), (b)(2), and (c) and further, that any such publications shall be limited to the specific purpose(s) described and approved in the Application. The Recipient shall not publish or disclose in any public paper, report, website, statistical tabulation or similar document any data on ten (10) or fewer individuals or data derived from ten (10) or fewer claims.
Disclosure of Findings. When a prospective employer seeks to review an employee’s disciplinary record, the Department will only disclose investigations with a finding of Substantiated, Exonerated- Other Violations Noted, Improper Action, or Secondary Violations Substantiated to the prospective employer. IA will prepare an Employer Disclosure Form setting forth all investigations with the above- referenced findings and any other required disclosures under Virginia Code § 15.2-1705. Employees may request to review the prepared Employer Disclosure Form and compare it to their control card before the form is produced to any prospective employer.
Disclosure of Findings. The User agrees not to disclose, with or without direct physician identifiers, direct findings, listings, or information derived from the file(s) specified in Section 5 of the DUA, if such findings, listings, or information can, by themselves or in combination with other data, be used to deduce a physician’s total Medicare reimbursements.
Disclosure of Findings. Nothing in the Data Use Agreement, including but not limited to Section 9, prohibits User from discussing or reporting on specific individuals or incidents in a manner consistent with Section A-2 and 42 CFR 401, Subpart G. A-5. Data linking: So long as the resulting files are only used in a manner consistent with 42 CFR 401, subpart G, nothing in the Data Use Agreement, including but not limited to Section 10, prohibits User from linking information derived from the files specified in Section 5 of the Data Use Agreement to other sources of individually-identifiable (patient-specific) health information, such as medical records, available to the QE and its contractors. When using or disclosing protected health information (PHI) or personally identifiable information (PII), obtained under the Data Use Agreement, User must make “reasonable efforts to limit” the information to the “minimum necessary” to accomplish the intended purpose of the use, disclosure or request. A-6. Prohibition on Data Reuse: Nothing in the Data Use Agreement, including but not limited to Section 11, prohibits User from reusing the data specified in Section 5 for any and all uses consistent with the requirements of 42 CFR 401, Subpart G. All other reuses are subject to the provisions of Section 11 of the DUA.
Disclosure of Findings. Nothing in the Data Use Agreement, including but not limited to Section 9, prohibits Users from discussing or reporting on specific individuals or incidents in a manner consistent with Section A-2 and 42 CFR 401, Subpart g.
AutoNDA by SimpleDocs

Related to Disclosure of Findings

  • DISCLOSURE OF FINANCIAL INFORMATION 26.1 The Customer represents and warrants that the financial information disclosed to us in his/its Application is an accurate representation of the Customer’s current financial condition. 26.2 The Customer represents and warrants that the Customer has very carefully considered the portion of the Customer’s assets which the Customer considers to be risk capital. 26.3 The Customer recognizes that risk capital is the amount of money the Customer is willing to put at risk and the loss of it would not, in any way, change the Customer’s lifestyle. 26.4 The Customer agrees to immediately inform us if the Customer’s financial condition changes in such a way to reduce the Customer’s net worth, liquid assets and/or risk capital.

  • Disclosure of Agreement The terms of this Settlement Agreement will be treated as confidential by the parties hereto until accepted by the Hearing Panel, and forever if, for any reason whatsoever, this Settlement Agreement is not accepted by the Hearing Panel, except with the written consent of both the Respondent and Staff or as may be required by law.

  • Disclosure of Sales The Company will disclose in its quarterly reports on Form 10-Q and in its annual report on Form 10-K the number of Placement Securities sold through the Sales Agent and any Alternative Sales Agent, the Net Proceeds to the Company and the compensation payable by the Company to the Sales Agent and any Alternative Sales Agent with respect to such Placement Securities.

  • Disclosure of Agreements The agreements and documents described in the Registration Statement, the Preliminary Prospectus and the Prospectus conform to the descriptions thereof contained therein and there are no agreements or other documents required to be described in the Registration Statement, the Preliminary Prospectus or the Prospectus or to be filed with the Commission as exhibits to the Registration Statement, that have not been so described or filed. Each agreement or other instrument (however characterized or described) to which the Company is a party or by which its property or business is or may be bound or affected and (i) that is referred to in the Registration Statement, Preliminary Prospectus or the Prospectus or attached as an exhibit thereto, or (ii) is material to the Company’s business, has been duly and validly executed by the Company, is in full force and effect in all material respects and is enforceable against the Company and, to the Company’s knowledge, the other parties thereto, in accordance with its terms, except (x) as such enforceability may be limited by bankruptcy, insolvency, reorganization or similar laws affecting creditors’ rights generally, (y) as enforceability of any indemnification or contribution provision may be limited under the federal and state securities laws, and (z) that the remedy of specific performance and injunctive and other forms of equitable relief may be subject to the equitable defenses and to the discretion of the court before which any proceeding therefor may be brought, and none of such agreements or instruments has been assigned by the Company, and neither the Company nor, to the Company’s knowledge, any other party is in breach or default thereunder and, to the Company’s knowledge, no event has occurred that, with the lapse of time or the giving of notice, or both, would constitute a breach or default thereunder. To the Company’s knowledge, performance by the Company of the material provisions of such agreements or instruments will not result in a material violation of any existing applicable law, rule, regulation, judgment, order or decree of any governmental agency or court, domestic or foreign, having jurisdiction over the Company or any of its assets or businesses, including, without limitation, those relating to environmental laws and regulations.

  • Disclosure of Material Matters Immediately upon learning thereof, report to Agent all matters materially affecting the value, enforceability or collectibility of any portion of the Collateral including, without limitation, any Borrower's reclamation or repossession of, or the return to any Borrower of, a material amount of goods or claims or disputes asserted by any Customer or other obligor.

  • Disclosure of Information Holder is aware of the Company’s business affairs and financial condition and has received or has had full access to all the information it considers necessary or appropriate to make an informed investment decision with respect to the acquisition of this Warrant and its underlying securities. Holder further has had an opportunity to ask questions and receive answers from the Company regarding the terms and conditions of the offering of this Warrant and its underlying securities and to obtain additional information (to the extent the Company possessed such information or could acquire it without unreasonable effort or expense) necessary to verify any information furnished to Holder or to which Holder has access.

  • Nondisclosure of Information To the extent necessary for the execution of this Agreement or to satisfy the requirements for disclosure to participants or to meet the requirements of Sections 8 and 9, the Advisor shall keep in strict confidence all information about the financial affairs of the Subaccount. The Advisor may include information about the Subaccount in aggregate information provided by the Advisor as long as the information is not set out separately or in any other manner that would enable a third party to determine the financial affairs of the Subaccount.

  • Disclosure of Material Information The Company covenants and agrees that neither it nor any other person acting on its behalf has provided or will provide any Purchaser or its agents or counsel with any information that the Company believes constitutes material non-public information, unless prior thereto such Purchaser shall have executed a written agreement regarding the confidentiality and use of such information. The Company understands and confirms that each Purchaser shall be relying on the foregoing representations in effecting transactions in securities of the Company.

  • Disclosure of Information to Third Parties We may disclose information to third parties about your Card or the transactions you make: (a) where it is necessary for completing transactions; (b) to verify either a transaction you make or the existence and condition of your Card to a third party; (c) to utilize services of third parties and affiliate entities who assist us in providing the Card and related services; (d) to comply with government agency rules or court orders; (e) if you give us your permission; (f ) if you owe us money or there are legal proceedings in connection with your Card, information may be released to attorneys, accounts, collection bureaus, financial institutions, and others involved in collection, adjustment, settlement or reporting; (g) to protect against potential fraud and other crimes; or (h) when otherwise permitted by law. We may also share information about you and your Card, based on our transactions and experiences with you, with our parent, affiliate, and subsidiary companies. You authorize us to make such credit, employment and investigative inquiries, as we deem appropriate in connection with the issuance and use of the Card. We can furnish information concerning the Card or creditable to consumer reporting agencies and others who may properly receive that information.

  • Disclosure of Litigation A. The Grantee must disclose in writing to the contract manager assigned to this Grant Agreement any material civil or criminal litigation or indictment either threatened or pending involving the Grantee. “Threatened litigation” as used herein shall include governmental investigations and civil investigative demands. “Litigation” as used herein shall include administrative enforcement actions brought by governmental agencies. The Grantee must also disclose any material litigation threatened or pending involving Subcontractors, consultants, and/or lobbyists. For purposes of this section, “material” refers, but is not limited, to any action or pending action that a reasonable person knowledgeable in the applicable industry would consider relevant to the Work under the Grant Agreement or any development such a person would want to be aware of in order to stay fully apprised of the total mix of information relevant to the Work, together with any litigation threatened or pending that may result in a substantial change in the Xxxxxxx’s financial condition.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!